Open AccessDefinitive treatment of Graves’ disease in children
Author(s) -
Tatiana Ivannikova,
Tatyana Shiryaeva,
Elegaeva,
М. С. Шеремета,
Д. Н. Бровин,
О. Б. Безлепкина
Publication year - 2022
Publication title -
problemy èndokrinologii
Language(s) - English
Resource type - Journals
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl13086
Subject(s) - medicine , graves' disease , radioactive iodine , thyroid , thyroidectomy , retrospective cohort study , medical treatment , radical surgery , disease , iodine , surgery , stage (stratigraphy) , pediatrics , cancer , intensive care medicine , paleontology , materials science , metallurgy , biology
BACKGROUND : Hyperthyreoidism due to Graves’ disease is a rare disorder in pediatric practice. There is 2 treatment options in Graves’ disease: medical treatment and definitive treatment, including surgery and radioactive iodine. Each method has its advantages and disadvantages. If medical therapy is ineffective the choice between radical treatment method is raised: radioactive iodine or total thyroidectomy. In this research we analyze treatment outcomes in pediatric Graves’ disease patients after different radical treatment methods. AIM : Comparative analysis of radical treatment outcomes in pediatric patients with Graves’ disease. MATERIALS AND METHODS : Retrospective and prospective one-center research of 122 patients with Graves’ disease after radical treatment (between 2016 and 2021) RESULTS : The mean age was 13.5±3,5 year at the moment of examination. Patients were divided into 2 groups due to the radical treatments method: 1 group (n=60) were children after surgical treatment, 2 group (n=62) — after radioactive iodine. The mean dose of medical treatment in these groups did not reliably differ (p=0,06), duration of the medical treatment was reliably longer in patients after radioactive iodine (p=0,024). Graves’ orbitopathy was diagnosed in 58 patients (47,5%) and met equally often in both groups, but active stage of Graves’ orbitopathy was diagnosed only in patients from the 1st group. Thyroid size was reliable bigger in patients from the 1st group (p=0,004), and thyroid gland nodes were diagnosed only in patients from 1st group (p=0,0007). CONCLUSION : RI can be considered an effective and safe treatment for GD. The effectiveness of RI depends on the volume of the thyroid gland; according to the results of the constructed ROC curve, the risk of repeated RI is higher with a volume of more than 55 cm3. Also radioactive iodine is undesirable if there is signs of ophatalmopathy due to its possible deterioration. According to the results of the study hypoparathyroidism after surgical treatment was diagnosed in 20%, recurrent laryngeal nerve injury was diagnosed after surgical treatment in 5% of patients. In patients with identified nodular goiter according to the results of ultrasound, surgical treatment is preferable due to the impossibility of excluding thyroid cancer.